Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Walmart | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $792.01B | 40.5x | 1.5 | $98.61 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.6% Upside | Upgrade to Pro+ | |
Kroger | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $46.80B | 17x | 0.36 | $64.82 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.4% Upside | Upgrade to Pro+ | |
Seven & i Co | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $36.96B | 52.6x | -1.1 | $14.23 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seven i ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $36.96B | 52.6x | -1.1 | $14.29 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sysco | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $36.95B | 19.3x | -4.02 | $75.54 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.4% Upside | Upgrade to Pro+ | |
Fomento Economico Mexicano | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $33.66B | 51.3x | -0.29 | $94.08 | -0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15% Upside | Upgrade to Pro+ | |
Koninklijke Ahold ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $32.16B | 17.8x | -6.76 | $35.22 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.2% Upside | Upgrade to Pro+ | |
Koninklijke Ahold NV | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $32.16B | 17.8x | -6.73 | $36.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tesco PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $31.94B | 20.1x | -2.91 | $4.75 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tesco PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $31.94B | 20.1x | -2.91 | $14.49 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.3% Downside | Upgrade to Pro+ | |
Aeon ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $20.98B | 296.9x | -3.88 | $24.54 | -0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Coles Group | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $16.56B | 23.7x | 13.03 | $13.30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
US Foods | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $16.48B | 34.7x | $71.68 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.7% Upside | Upgrade to Pro+ | ||
Caseys | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | $15.32B | 28.6x | 2.55 | $414.21 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10% Upside | Upgrade to Pro+ | |
Sprouts Farmers | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | $14.67B | 39.6x | 0.75 | $148.40 | 3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.2% Upside | Upgrade to Pro+ | |
CP All ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $14.17B | 19.5x | 0.43 | $16 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jeronimo Martins SGPS SA ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $13.32B | 20.3x | -1.58 | $42.82 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.3% Upside | Upgrade to Pro+ | |
Performance Food Group Co | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $13.25B | 33.7x | -3.48 | $85.14 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.8% Upside | Upgrade to Pro+ | |
Albertsons | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $12.21B | 11.7x | -0.47 | $21.04 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.3% Upside | Upgrade to Pro+ | |
Dino Polska ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $11.48B | 33.9x | 10.35 | $63.31 | 8.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Luckin Coffee | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $9.56B | 23.6x | 8.46 | $29.75 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.6% Upside | Upgrade to Pro+ | |
Walgreens Boots | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | $9.23B | -1x | 0 | $10.68 | -4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.4% Upside | Upgrade to Pro+ | |
Marks & Spencer Group Plc | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $9.03B | 14x | 0.58 | $9.15 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.8% Upside | Upgrade to Pro+ | |
Marks and Spencer | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $9.03B | 14x | 0.58 | $4.28 | 4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Carrefour SA PK | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $8.56B | 11.8x | -0.21 | $2.62 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.2% Upside | Upgrade to Pro+ | |
Shoprite ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $8.15B | 24.2x | 3.73 | $14.78 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sendas Distribuidora | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $7.62B | 70.8x | $5.65 | -4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25% Upside | Upgrade to Pro+ | ||
Kesko ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $7.57B | 19.1x | -0.8 | $9.37 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
J Sainsbury PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $7.48B | 103.3x | -1.26 | $13.20 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -8.4% Downside | Upgrade to Pro+ | |
Raia Drogasil ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $4.99B | 26.1x | 6.97 | $2.92 | -7.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Etablissementen Franz Colruyt ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $4.81B | 13.4x | -0.2 | $9.82 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Axfood ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $4.60B | 22.3x | -3.07 | $25.22 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Clicks Group | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $4.43B | 29.5x | 2.07 | $37.02 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DFI Retail Holdings DRC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $2.99B | 24.6x | 0.07 | $11 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BBB Foods | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $2.94B | 245.1x | 1.83 | $26.62 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.6% Upside | Upgrade to Pro+ | |
The Chefs Warehouse | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | $2.51B | 42.5x | 0.91 | $62.58 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.2% Upside | Upgrade to Pro+ | |
Sun Art Retail ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $2.18B | -15.5x | 0.03 | $2.27 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Weis Markets | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $1.99B | 20.7x | -1.37 | $73.98 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hellofresh | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $1.98B | -16.8x | 0.05 | $13.25 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
United Natural Foods | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $1.89B | -20.1x | 1.32 | $31.79 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.1% Downside | Upgrade to Pro+ | |
Green Thumb Industries | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $1.70B | 23.3x | 0.06 | $6.95 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SPAR ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $1.51B | 78.6x | -1.35 | $6.85 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vital Farms | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | $1.44B | 26x | 0.2 | $33.11 | 7.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 43.1% Upside | Upgrade to Pro+ | |
Pick N Pay ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $1.19B | -4.6x | 0 | $6.84 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ingles | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | $1.18B | 14.8x | -0.27 | $61.44 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Guardian Pharmacy Services | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | $1.17B | -13.8x | $20 | 8.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.8% Upside | Upgrade to Pro+ | ||
Grocery Outlet | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | $1.16B | 29.9x | -0.8 | $11.87 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.3% Upside | Upgrade to Pro+ | |
Robinsons Retail Holdings Inc | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | $906.66M | 5.2x | 0.03 | $5.89 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SpartanNash Co | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | $681.12M | 2,240x | -22.34 | $20.19 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3% Upside | Upgrade to Pro+ | |
Village Super Market | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | $463.49M | 9x | 3.81 | $31.50 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |